Pelthos Therapeutics Shares Fall About 35% After Castle Creek Merger Deal
Photo: TokenPost
Pelthos Therapeutics Inc. (PTHS) shares were at $10.79 Friday, Oct. 30, down about 35% after the company agreed to combine with Castle Creek Biosciences (CCBS). The proposed deal would broaden Pelthos’ portfolio with cell and gene therapies aimed at serious skin diseases. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
